To provide a concise, pathophysiology-based overview of components of distributive shock other than vasoplegia that modulate its clinical presentation and therapeutic response, focusing on septic shock.
Approach:
Microcirculatory alterations: Describes changes in capillary density, perfusion heterogeneity, and endothelial dysfunction in septic shock, highlighting the complexity of tissue perfusion and the relationship between macro- and microcirculation.
Bioenergetic, metabolic and endocrine alterations: Explores metabolic shifts, mitochondrial dysfunction, and endocrine disruptions in septic shock, emphasizing the impact on organ function and the need for targeted interventions.
Cardiomyopathy: Discusses sepsis-induced cardiomyopathy (SICM) as a significant factor in septic shock, noting its variability and potential for reversibility among survivors.
Key Findings:
Distributive shock in sepsis involves complex interactions beyond vasoplegia, including microcirculatory and metabolic disturbances.
Microcirculatory alterations lead to impaired autoregulation and variability in perfusion, with limited evidence of significant tissue hypoxia.
Bioenergetic dysfunction reflects a metabolic reprogramming that can lead to organ dysfunction and poor outcomes.
SICM presents with variable systolic dysfunction and can influence the hemodynamic response in septic shock.
Interpretation:
The pathophysiology of septic shock is multifaceted, requiring a comprehensive understanding of various components beyond vasoplegia for effective management.
Limitations:
The complexity of septic shock pathophysiology may complicate the identification of effective therapies.
Short-term observational data limit the understanding of SICM's long-term implications.
Conclusion:
A deeper understanding of the various pathophysiological components of septic shock is essential for improving therapeutic strategies.
